Document Details

Form
Filing Date
Apr 17, 2026
Document Date
Apr 15, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Keros Therapeutics
Issuer
Keros Therapeutics, Inc.
Filer
BIENAIME JEAN JACQUES

Investor Contact